Skip to main content
. Author manuscript; available in PMC: 2015 Dec 1.
Published in final edited form as: Cancer. 2014 Aug 7;120(23):3717–3721. doi: 10.1002/cncr.28902

Table 4.

Cox regression analyses of Hepatobiliary Module (symptoms and side effects) of the FACT-Hepatobiliary and survival after adjusting for demographic, disease-, and treatment-related predictors

Variable B p-value Hazard
Ratio
95% Confidence
Interval
Lower Upper
AGE
  Ref: <50 years .037 .925 1.038 .479 2.249
GENDER
  Ref: male .406 .177 1.501 .833 2.706
MELD .006 .849 1.006 .949 1.066
TUMOR SIZE
  Ref: <5cm .481 .043 1.617 1.016 2.574
LESION NUMBER
  Ref: <2 −.786 .001 .456 .289 .719
VASCULARITY
  Ref: hypervascular .248
  Mixed vascularity −.854 .120 .426 .145 1.251
  Hypovascular −.966 .099 .381 .121 1.201
VASCULAR INVASION .815 .001 2.259 1.402 3.641
TREATMENT
  Ref: TACE .244
  90 Yttrium .655 .189 1.924 .725 5.107
  No treatment .240 .659 1.271 .439 3.679
  Radiofrequency Ablation 1.661 .160 5.265 .518 53.492
  Resection .145 .857 1.156 .238 5.622
HepCS
  Ref: lowest tertile .043
  Middle tertile .686 .028 1.986 1.075 3.668
  Highest tertile .678 .025 1.970 1.088 3.568